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Introduction {#sec1}
============

Reactive oxygen species (ROS) are important signaling molecules that regulate cellular metabolism, proliferation, and survival ([@bib36]). An increase of ROS induces the thiol oxidation of cysteine residues on signaling proteins, resulting in alterations of protein activities to regulate cellular functions. In particular, ROS-mediated oxidation plays an important role in regulating a variety of signaling proteins in stem cells (SCs) that influence self-renewal capacity, pluripotency, viability, and genomic stability, including OCT4, NRF2, FoxOs, APE1/Ref-1, ATM, HIF-1, p38, and p53 ([@bib35]). For example, OCT4, a pluripotency-related transcription factor, is inactivated via cysteine oxidation under glutamine-depleted conditions, favoring the differentiation and functional maturation of embryonic SCs (ESCs) ([@bib25]). Disruption of *Nrf2*, a master regulator of redox homeostasis, impinges upon the functions of embryonic and adult SCs such as the self-renewal and pluripotency in ESCs ([@bib16]), the migration and retention of hematopoietic SCs in the bone marrow niche ([@bib33]), and the proliferation and homeostasis in intestinal ([@bib13]) and airway basal SCs ([@bib31]). Thus, the cellular redox regulation is critical for maintaining stemness and functional potency of ESCs and adult SCs.

Cellular redox homeostasis depends on the balance between ROS production and their elimination via enzymes and antioxidant molecules such as glutathione (GSH), a thiol-containing tripeptide that plays a major role in maintaining redox homeostasis owing to its high concentration (approximately 1--10 mM). GSH is synthesized in the cytosol and is then transported to cellular compartments such as the mitochondria, nucleus, and ER, where redox buffering is required for organelle-specific functions. GSH eliminates hydrogen peroxide (H~2~O~2~) through a glutathione peroxidase-catalyzed reaction, producing water and oxidized GSH (GSSG), which is regenerated to GSH by glutathione reductase at the expense of NADPH ([@bib23]). Therefore, changes in the GSH levels in response to oxidative stress can reflect the redox buffering capacity of a particular cell type or cellular compartment. Moreover, GSH also acts as a regulator for ROS-triggered signal transmission. GSH reduces ROS-induced disulfides in signaling proteins, either by glutaredoxin or by forming *S*-glutathionylated proteins through a thiol-disulfide exchange reaction, thereby modulating the intensity and duration of redox signaling ([@bib36]). Furthermore, ESCs and inducible pluripotent SCs harbor particularly high GSH levels, which confer protection against unfavorable DNA damage ([@bib6]). Thus, monitoring the dynamic changes of GSH levels in living SCs is required to evaluate the redox buffering capacity and signaling processes that modulate SC functions during several physiological and pathological processes. However, obtaining a detailed understanding of the GSH-based redox system has thus far been limited owing to the lack of direct and reliable tools.

Various techniques have been used to estimate GSH levels in living cells to date, including redox-sensitive fluorescent proteins such as rxYFP and roGFP ([@bib10]). Since the thiol-disulfide status of these fluorescent proteins is in equilibrium with that of cellular GSH, this method can provide information on the GSH/GSSG redox potential but cannot directly monitor the changes in GSH levels. In addition, the poor efficiency of transfection and consequent cellular damage hinder the application of this genetic method for a wide range of cell types. Several thiol-reactive fluorescent chemical dyes have also been developed as GSH sensors to overcome these problems ([@bib37]). However, these dyes still have drawbacks such as irreversibility, slow kinetics ([@bib19]), low fluorescence quantum yields ([@bib3]), or limited subcellular localization ([@bib34]). Moreover, previous works on GSH monitoring have not paid enough attention to the possible errors caused by reactive thiols in cellular proteins.

To overcome the limitations of current GSH probes, we previously reported the synthesis of a coumarin derivative bearing a conjugated 2-cyanoacrylamide group, designated FreSHtracer (fluorescent real-time thiol tracer; [Figure 1](#fig1){ref-type="fig"}A), which reacts reversibly with thiols in aqueous solutions ([@bib5]). The present study showed that FreSHtracer is a powerful tool for real-time monitoring of GSH dynamics and heterogeneity in living SCs, and revealed that SCs cultured under conventional conditions exhibit the downregulation of GSH levels that results in deterioration of self-renewal and migration function. Therefore, our results prove that monitoring glutathione contents and dynamics in living SCs can be used as a marker to evaluate SC function and enhance its therapeutic potency.Figure 1FreSHtracer Is a Reversible and Ratiometric Probe for Glutathione(A) Changes in the absorption and fluorescence spectra of FreSHtracer when reacted with increasing concentrations of glutathione (GSH).(B) Fluorescence ratio (F~510~/F~580~; FR) of FreSHtracer plotted as a function of the GSH concentration.(C) Reversible reaction of FreSHtracer with GSH following treatment with diamide.(D and E) GSH-specific reaction of FreSHtracer. FreSHtracer equilibrated with GSH (5 mM; 15 min) was treated with H~2~O~2~ (0--2 mM) (D), and FreSHtracer equilibrated with oxidized GSH (GSSG, 5 mM) was treated with GSH reductase (5 U/mL) and 0.5 mM NADPH (E).(F and G) Fluorescence properties of FreSHtracer in dialyzed cell lysates. The FR change was monitored in dialyzed HeLa cell lysates (F) and then plotted against the protein concentration (G).(H) Effect of oxidants on the PSH-induced FR. Dialyzed cell lysates (25 mg/mL protein) were incubated with FreSHtracer (2 hr) and treated with diamide or H~2~O~2~ for 1 hr.(I and J) Fluorescence properties of FreSHtracer in PSH-GSH mixtures. FreSHtracer was added to dialyzed cell lysates (25 mg/mL protein) spiked with various GSH concentrations. The FR change was monitored for 20 min (I). The final FR value was plotted against the GSH concentration (J).(K) Effect of oxidants on the FR of the PSH-GSH mixture. PSH-GSH mixtures (25 mg/mL protein and 2 mM GSH) were incubated with FreSHtracer (2 hr) and treated with diamide or H~2~O~2~ for 1 hr.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Results {#sec2}
=======

FreSHtracer Is a Ratiometric Probe Suitable for Measuring and Monitoring GSH Levels {#sec2.1}
-----------------------------------------------------------------------------------

We first investigated whether FreSHtracer could be suitable for measuring and monitoring GSH levels even in the presence of abundant cellular protein thiols. In the reaction with GSH, FreSHtracer showed a spectral shift of the λ~max~ of its ultraviolet-visible absorption from 520 nm to 430 nm, resulting in decreased fluorescence emission intensity at 580 nm (F~580~, λ~ex~ 520 nm) and increased fluorescence intensity at 510 nm (F~510~, λ~ex~ 430 nm; [Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). The apparent dissociation constant (*K*~D~) value for GSH was estimated at 3.6 mM and was unaffected by pH changes ranging from 6.0 to 9.0 ([Table S1](#mmc1){ref-type="supplementary-material"} and [Figure S1](#mmc1){ref-type="supplementary-material"}B). Notably, the F~510~/F~580~ ratio (FR) correlated with the GSH concentration (R^2^ = 0.9938; [Figure 1](#fig1){ref-type="fig"}B), indicating that FreSHtracer can ratiometrically report the GSH concentration. When GSH was added to FreSHtracer, the FR rapidly increased, reaching a plateau within 5 min ([Figure 1](#fig1){ref-type="fig"}C), and was then stoichiometrically decreased by treatment with the thiol-specific oxidants diamide and *N*-ethylmaleimide (NEM), as well as with H~2~O~2~ treatment in a dose-dependent manner ([Figures 1](#fig1){ref-type="fig"}C, 1D, and [S1](#mmc1){ref-type="supplementary-material"}C--S1E), demonstrating a reversible reaction with GSH. Moreover, the FR was unchanged by treatment with GSSG and only increased when both glutathione reductase and NADPH were added to the mixture to reduce GSSG to GSH ([Figure 1](#fig1){ref-type="fig"}E), indicating the specific reaction of FreSHtracer with GSH.

We next characterized the reaction between FreSHtracer and accessible cysteine thiols in cellular proteins (PSH), which were estimated at a concentration of 1.95 ± 0.11 mM in 25 mg/mL protein of the HeLa cell lysates using Ellman\'s assay, comprising up to 70% of the total cellular thiols ([@bib11]). When added to diluted protein solutions, the FR slowly increased, reaching a plateau after 90 min ([Figure 1](#fig1){ref-type="fig"}F) in a protein concentration-dependent manner, but remained constant in concentrated protein solutions ([Figure 1](#fig1){ref-type="fig"}G). These results were confirmed by calculation of the rate constants, showing that the reaction with PSH was approximately 12-fold slower than that with GSH ([Figure S1](#mmc1){ref-type="supplementary-material"}F). The FR of protein solutions decreased by treatment with diamide, but not with H~2~O~2~, indicating that PSH is oxidized by diamide but resistant to H~2~O~2~-induced oxidation ([Figures 1](#fig1){ref-type="fig"}H and [S1](#mmc1){ref-type="supplementary-material"}G). When the changes in the FR of FreSHtracer were monitored in protein solutions spiked with various concentrations of GSH, the FR was found to increase rapidly within 5 min and then gradually increased further over a period of 1.5 hr ([Figures 1](#fig1){ref-type="fig"}I and [S1](#mmc1){ref-type="supplementary-material"}H), showing the combined kinetics for GSH and PSH. Moreover, when plotted against the GSH concentration, the FR was shown to increase in a GSH-concentration-dependent manner ([Figure 1](#fig1){ref-type="fig"}J). Although the FR was affected by the cellular proteins added, this dependency on the protein concentration became less significant at higher concentration ranges ([Figure S1](#mmc1){ref-type="supplementary-material"}I). Therefore, the FR is expected to be mainly dependent on the GSH concentration and not significantly affected by typical protein concentration variations (50--200 mg/mL) in intact cells ([@bib8]). Considering that the PSH-induced FR remained constant, these results imply that the total FR could be divided into GSH- and PSH-dependent FR values (FR~GSH~ and FR~PSH~, respectively). Consistently, treatment with H~2~O~2~ diminished only the FR~GSH~ with no effect on the FR~PSH~, whereas treatment with diamide resulted in a dose-dependent decrease in both FR~PSH~ and FR~GSH~ ([Figures 1](#fig1){ref-type="fig"}K and [S1](#mmc1){ref-type="supplementary-material"}G). Thus, these results demonstrate that FreSHtracer is capable of monitoring the ROS-induced GSH changes in a cell homogenate.

GSH Levels Are Heterogeneous in the Subcellular Organelles of Living Cells {#sec2.2}
--------------------------------------------------------------------------

Next, to utilize FreSHtracer for GSH monitoring in living cells, we evaluated its cytotoxicity. Treatment of up to 10 μM FreSHtracer for 24 hr showed no effect on the viability of HeLa cells and human mesenchymal SCs derived from bone marrow (hBM-MSCs) and ESCs (hES-MSCs) ([@bib14]) ([Figure S2](#mmc1){ref-type="supplementary-material"}). HeLa cells were equilibrated with treatment of 5 μM FreSHtracer for 2 hr. Confocal and ratiometric pseudo-color images revealed that FreSHtracer was distributed inside the cells, exhibiting a wide range of FR values ([Figure 2](#fig2){ref-type="fig"}A). The FR in the nucleus was about 1.5- to 2-fold higher than that of the cytoplasm. The FR of the nucleolus revealed relatively lower GSH levels, and the FR of the peripheral cytoplasm was higher than that of other regions. Moreover, variable FR values were observed in the cytoplasm, which produced a mosaic pattern in the pseudo-color images, possibly arising from GSH in the ER and mitochondria. When HeLa cells were treated with diamide following equilibration with 5 μM FreSHtracer for 2 hr, the FR gradually decreased by diamide (or NEM) and then rapidly increased by DTT ([Figures 2](#fig2){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}), demonstrating that FreSHtracer reacts reversibly with thiols in the intracellular environment.Figure 2FreSHtracer Visualizes GSH Levels within Subcellular Compartments in Living Cells(A) Representative confocal images of F~510~ and F~580~, and pseudo-color images of the fluorescence ratio (FR) for HeLa cells, hBM-MSCs, and hES-MSCs. The cells were incubated with FreSHtracer (5 μM) for 2 hr. Images of a HeLa cell and hBM-MSCs are the same, with cells indicated by arrows in [Figure 4](#fig4){ref-type="fig"}A (0 min).(B) A reversible reaction of FreSHtracer with intracellular thiols. In HeLa cells equilibrated FreSHtracer (5 μM, 2 hr), F~510~ and F~580~ were monitored at 5-s intervals after treatment with diamide (DA), followed by 0.5 mM DTT. (a) Confocal and pseudo-color images of FreSHtracer-loaded cells indicated by numbered arrowheads. (b and c) The F~510~, F~580~, and FR of the two cells (arrowheads) were monitored. (d) The average FR values in the whole cell, cytoplasm, and nucleoplasm (n = 4 cells/time point) are shown.(C) The structure of MitoFreSHtracer, and changes in its fluorescence spectra when reacted with GSH.(D) Confocal and ratiometric pseudo-color images of a MitoFreSHtracer-loaded (10 μM, 1.5 hr) HeLa cell.Images are the same with the cell indicated by arrowhead 1 in E (0 min).(E) Effect of DA (0.5 mM) on the FR within MitoFreSHtracer-loaded HeLa cells. Left: pseudo-color images of the FR. Right: time course of FR changes within the indicated cells (arrowheads).(F) Effect of antimycin A (0, 100, 200 μM; 75 min) on FR values in MitoFreSHtracer-loaded HeLa cells. Left: pseudo-color images of the FR. Right: concentration-dependent decreases in the FR values within antimycin A-treated cells (n = 90 cells from n = 3 independent experiments).Data represent the mean ± SEM of the FR; ^∗∗∗^p \< 0.001. Scale bars, 10 μm (A, B, D, E, F). See also [Figures S2--S4](#mmc1){ref-type="supplementary-material"}.

The mitochondrion is the major site of endogenous ROS generation during normal oxidative metabolism ([@bib1]). Cytosolic GSH is transported to the mitochondria, preventing macromolecular damage and modulating ROS-induced signaling ([@bib24]). To further analyze the FR heterogeneity in the cytoplasm, we synthesized a mitochondria-targeting FreSHtracer derivative, designated MitoFreSHtracer ([Figure 2](#fig2){ref-type="fig"}C), by attaching a triphenylphosphonium moiety to FreSHtracer ([@bib29]). MitoFreSHtracer reacted rapidly and reversibly with GSH, exhibited GSH-dependent FR values similar to those of FreSHtracer (*K*~D~ = 1.3 mM, [Figures S4](#mmc1){ref-type="supplementary-material"}A--S4C), and showed no cytotoxic effect on HeLa cells with treatment up to 10 μM for 24 hr ([Figure S4](#mmc1){ref-type="supplementary-material"}D).

Confocal images revealed that MitoFreSHtracer localized to the mitochondria in HeLa cells ([Figure 2](#fig2){ref-type="fig"}D), and the FR decreased upon diamide treatment ([Figure 2](#fig2){ref-type="fig"}E), indicating that GSH levels within the mitochondria can be monitored by MitoFreSHtracer. Remarkably, there was wide variation in the FR values among mitochondria within a single cell, even under normal culture conditions ([Figure 2](#fig2){ref-type="fig"}D), indicating that the GSH levels in the mitochondria of a single cell are heterogeneous. Moreover, a concentration-dependent decrease in the FR was observed when the cells were treated with antimycin A, which generates ROS in mitochondria by inhibiting electron transport ([@bib7]) ([Figure 2](#fig2){ref-type="fig"}F). Simultaneous analyses showed that mitochondrial ROS levels increased with treatment of DHR123, a non-fluorescent rhodamine derivative that localizes to the mitochondria and emits fluorescence when oxidized by ROS ([Figures S4](#mmc1){ref-type="supplementary-material"}E and S4F). Taken together, these results demonstrate that GSH levels differ among organelles as well as among different regions within the same compartment of a live cell.

Real-Time Measurement of GSH Concentrations in Living Cells {#sec2.3}
-----------------------------------------------------------

Although GSH is the most abundant thiol in cells, proteins constitute a significant portion of cellular thiol ([@bib11]). Thus, we examined whether FreSHtracer could be not significantly affected by the presence of protein thiols for reporting the continuous changes of GSH levels in living cells. When HeLa cells were treated with various concentrations of buthionine sulfoximine (BSO) for 48 hr to suppress GSH synthesis, measurements of the FR in the GSH-depleted cells showed that the FR~GSH~ accounted for approximately 55% of the total FR in normal cells, and the intracellular GSH concentration, which was independently measured by luminescence-based assays in cell lysates, was directly correlated with the FR determined by confocal microscopy (R^2^ = 0.9135; [Figure 3](#fig3){ref-type="fig"}A) and flow cytometry (R^2^ = 0.9753; [Figure 3](#fig3){ref-type="fig"}B).Figure 3FreSHtracer Can Report the GSH Concentration within Live Cells(A and B) Determination of the F~510~/F~580~ ratio (FR) fraction attributable to GSH (FR~GSH~). The FR within buthionine sulfoximine (BSO)-treated HeLa cells (3--4 × 10^3^ cells/cm^2^; 48 hr) in confocal imaging of each cell (n = 10 cells; A) or the FR within flow-cytometric analysis of BSO-treated cells (n = 3 independent biological replicates; B) were plotted against the GSH concentration determined by luminescence-based methods following cell lysis (n = 3 independent biological replicates; A and B, right).(C--E) Effect of oxidants on the FR of GSH-depleted cells (FR~PSH~). BSO-treated HeLa cells (48 hr, 80 μM), equilibrated with FreSHtracer (2 hr, 5 μM), were treated for 15 min with (E) or without (C and D) 50 μM 1-chloro-2,4-dinitrobenzene (CDNB), an irreversible inhibitor of thioredoxin reductase. Fluorescence intensities were measured every 10 s by confocal microscopy following treatment with H~2~O~2~ (C) or diamide (DA; D and E). Ratiometric pseudo-color images (C--E, upper) depict the FR (n = 4 cells/time point; C--E, lower). Arrows indicate time points of treatment of H~2~O~2~ or diamide.All error bars represent mean ± SEM. Scale bars, 10 μm (A, C, D, E).

The *in vitro* experiments described above established that H~2~O~2~ treatment diminishes only the FR~GSH~, while having little effect on the FR~PSH~ ([Figures 1](#fig1){ref-type="fig"}H and 1K). In line with these *in vitro* data, the GSH-depleted cells showed no change in their FR values following the addition of either 100 μM or 500 μM H~2~O~2~ over a period of 40 min ([Figure 3](#fig3){ref-type="fig"}C), indicating that oxidation of GSH, and not PSH, caused the FR change in H~2~O~2~-treated cells. Thus, FreSHtracer can report the real-time dynamic changes of GSH concentration in live cells under oxidative stress. Interestingly, when the GSH-depleted cells were treated with diamide as a control experiment, the FR decreased but was then immediately restored to the original level ([Figure 3](#fig3){ref-type="fig"}D). This restoring activity was abrogated by treatment with 1-chloro-2,4-dinitrobenzene, an inhibitor of thioredoxin reductase ([Figure 3](#fig3){ref-type="fig"}E), indicating that thioredoxin, instead of GSH, is required to reduce the disulfides of PSH. These results indicate that FreSHtracer can successfully distinguish between GSH and PSH in living cells.

Cellular GSH Levels Dynamically Change under Oxidative Stress {#sec2.4}
-------------------------------------------------------------

ROS production by various cellular conditions significantly affected SC functions such as self-renewal and differentiation ([@bib15]). Thus, we monitored the H~2~O~2~-induced changes in GSH levels. When HeLa cells and hBM-MSCs were treated with H~2~O~2~, the FR decreased rapidly, then remained unchanged before increasing slowly, and ultimately returned to the untreated level. The profile and time course of FR changes in the cytoplasm and nucleoplasm were similar to those observed in whole cells ([Figure 4](#fig4){ref-type="fig"}A). Notably, GSH levels in HeLa cells were more sensitive to H~2~O~2~ treatment than those in hBM-MSCs. In HeLa cells treated with increasing concentrations of H~2~O~2~, both the decrease in the FR and the lag time for recovery were accentuated ([Figure 4](#fig4){ref-type="fig"}B).Figure 4Heterogeneity and Dynamic Changes of GSH Levels in Living Cells(A and B) HeLa cells and hBM-MSCs were incubated with FreSHtracer (5 μM) for 2 hr, and the fluorescence ratio (FR) changes in response to H~2~O~2~ treatment were monitored. HeLa cells and hBM-MSCs equilibrated with FreSHtracer (5 μM, 2 hr) were treated with 50 μM and 100 μM H~2~O~2~, respectively, and images were recorded every 10 s using a confocal microscope. Ratiometric pseudo-color images of cells (A, left) depicting the FR of whole cells, the cytoplasm, and the nucleoplasm (n = 7 cells/time point in HeLa cells; n = 20 cells/time point in hBM-MSCs; A, right), and the H~2~O~2~ concentration-dependent changes of FR in HeLa cells (B) are shown. A HeLa cell and hBM-MSCs images (A, left) indicated by arrows are reused in [Figure 2](#fig2){ref-type="fig"}A.(C) FR changes of RAW264.7 cells following phorbol 12-myristate 13-acetate (PMA) treatment. RAW264.7 cells equilibrated with FreSHtracer (4 hr, 5 μM) were treated with either ethanol (control) or PMA (0.5 μg/mL). Images were taken every 10 s using a confocal microscope. Left: ratiometric pseudo-color images of control and PMA-treated RAW264.7 cells. Right: FR changes following PMA treatment within the indicated cells (arrowheads).(D) Effect of serum deprivation on the FR. Following equilibration for 2 hr with 5 μM FreSHtracer, images were taken using a confocal microscope. Upper panel: pseudo-color images depicting the FR. Lower panel: FR within whole cells, the cytoplasm, and the nucleoplasm (n = 30 cells from n = 3 independent experiments).(E and F) Effect of cell confluence and passage on the FR. HeLa cells (1 × 10^4^, 2 × 10^4^, and 4 × 10^4^ cells/cm^2^) were cultured for 24 hr and incubated with FreSHtracer (5 μM, 2 hr), followed by confocal microscopy analysis (E, upper). The FR within whole cells, the cytoplasm, and the nucleoplasm was analyzed (n = 30 cells from n = 3 independent experiments; E, lower). hBM-MSCs were subcultured from passage number (P) 4.5 to 6 by seeding at three different densities (1 × 10^3^, 2 × 10^3^, and 4 × 10^3^ cells/cm^2^) and cultured for 3 days, following equilibration with FreSHtracer (2 μM, 2 hr; F, left). The cells were analyzed using flow cytometry (F, right).For all bar graphs, values represent mean ± SEM; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Scale bars, 10 μm (A, C, D, E).

To confirm these results, we monitored the GSH changes induced by endogenously produced ROS. In macrophages, ROS are produced by NADPH oxidase when the cells are activated. Therefore, RAW264.7 cells were loaded with FreSHtracer and treated with phorbol 12-myristate 13-acetate (PMA). Confocal microscopy revealed that the FR decreased gradually over 30 min upon PMA treatment in every region of the treated cells and was then slowly restored to the control level during the following 30 min ([Figure 4](#fig4){ref-type="fig"}C). Moreover, ROS production was also reported to increase in cells cultured at a low density or in serum-deprived medium ([@bib10]). Therefore, we monitored the effect of culture conditions on the changes of GSH levels. Exposure of HeLa cells to serum-free medium for 18 hr significantly reduced the FR in the cytoplasm and in the nucleoplasm ([Figure 4](#fig4){ref-type="fig"}D). When cultured at different densities, the average FR of densely cultured HeLa cells was significantly higher than that of sparsely cultured cells, despite the large variation in the FR, particularly in the nucleoplasm ([Figure 4](#fig4){ref-type="fig"}E).

We then extended these results to monitor the GSH levels in hBM-MSCs. The cells were serially subcultured at different seeding densities. Flow-cytometric analysis showed that the hBM-MSC populations were heterogeneous with respect to GSH levels, and, notably, the number of cells with a high GSH content (GSH^High^) gradually decreased with increasing passages, especially when cultured at a low cell density ([Figure 4](#fig4){ref-type="fig"}F), indicating that GSH levels in SCs depend on the culture conditions. Together, these results demonstrate that GSH levels are dynamically changed in response to oxidative stress, and that FreSHtracer can provide spatiotemporal information of GSH levels for estimating the redox buffering capacity of individual cells.

High GSH Levels Are Required for Stem Cell Function {#sec2.5}
---------------------------------------------------

To further explore the biological significance of the reprogrammed GSH levels in SCs, we sorted hBM-MSCs by flow cytometry and divided them into three subpopulations based on the FR (FR^High^, FR^Mid^, and FR^Low^ cells; [Figure S5](#mmc1){ref-type="supplementary-material"}A), following the rapid removal of FreSHtracer in sorted cells ([Figure S5](#mmc1){ref-type="supplementary-material"}B). When we compared the functional characteristics of sorted SC subpopulations *in vitro*, the FR^High^ hBM-MSCs, compared with FR^Mid^ and FR^Low^ cells, significantly enhanced the cellular functions regarding colony-forming unit fibroblasts (CFU-F) and the chemoattraction to platelet-derived growth factor (PDGF) ([Figures S5](#mmc1){ref-type="supplementary-material"}C and S5D).

To further validate the improved functionality of SCs with a high GSH content, via fluorescence-activated cell sorting we sorted hES-MSCs into FR^High^, FR^Mid^, and FR^Low^ subpopulations based on the FR ([Figure 5](#fig5){ref-type="fig"}A). The GSH concentrations in the cell lysates from each population were directly proportional to their FR levels, validating the FR-based sorting method ([Figure 5](#fig5){ref-type="fig"}B). Intriguingly, the decrease of FR and the lag time for recovery following treatment with 100 μM H~2~O~2~ were inversely proportional to the FR levels of the sorted cell population ([Figure 5](#fig5){ref-type="fig"}C). Moreover, the FR of FR^High^ cells recovered to higher than basal levels after H~2~O~2~ exposure, indicating that FR^High^ cells have greater GSH-restoring capacity compared with control cells.Figure 5Intracellular GSH Levels Modulate the Self-Renewal and Migration Activities of Mesenchymal Stem Cells(A) Sorting of hES-MSCs according to the F~510~/F~580~ ratio (FR) into three populations: FR^High^, FR^Mid^, and FR^Low^ cells. Cells were characterized as described below, following the removal of FreSHtracer.(B and C) Luminescence-based quantification of GSH in cell lysates (n = 2 independent biological replicates; B) and comparison of FR changes following treatment with 100 μM H~2~O~2~ (n = 3 cells; C) in FR^High^, FR^Mid^, and FR^Low^ hES-MSCs.(D--I) Analyses of cell proliferation (n = 6 independent biological replicates; D), colony-forming unit fibroblasts (CFU-F; n = 15 independent biological replicates; E), limiting dilution by replating primary CFU colonies (n = 6 independent biological replicates; F), chemotaxis to stromal derived factor-1α (SDF1α; 150 ng/mL, n = 8 independent biological replicates; G), chemotaxis to 10 ng/mL platelet-derived growth factor (PDGF)-AA in the absence or presence of STI571 (0.5 μg/mL), a PDGFR inhibitor (n = 8 independent biological replicates; H), and qPCR of *OCT4*, *SOX2*, *CXCR4*, *cMET*, *PDGFRA*, *PDGFRB*, *VEGFR1*, and *VEGFR2* (n = 8 independent biological replicates; I) in hES-MSCs sorted based on the FR and in unsorted control (naive) cells.(J--L) Functional role of high GSH levels in hES-MSCs. CFU-F (n = 10 independent biological replicates; J), chemotaxis to 10 ng/mL PDGF-AA (n = 8 independent biological replicates; K), and qPCR assays of stemness and migration-related genes (n = 4 independent biological replicates; L) in control and BSO-treated FR^High^ hES-MSCs or control and GSH-EE supplemented FR^Low^ cells.For all bar graphs, values represent mean ± SEM; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001; n.s., not significant. Scale bars, 200 μm (G and H). See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.

As shown in [Figure 5](#fig5){ref-type="fig"}D, the sorted hES-MSCs showed no significant difference in proliferation rate. When multipotency was examined, both FR^High^ and FR^Low^ cells exhibited a similar capacity to differentiate into chondrogenic, adipogenic, and osteogenic lineages ([Figure S6](#mmc1){ref-type="supplementary-material"}A), but FR^High^ hES-MSCs, compared with FR^Low^ cells, showed a significant increase in the induction of some lineage markers, including *SOX9*, *AP2*, and *OCN* ([Figure S6](#mmc1){ref-type="supplementary-material"}B). Additionally, FR^High^ hES-MSCs had approximately 4.7- and 4.9-fold higher numbers of CFU-F than did FR^Mid^ and FR^Low^ cells, respectively ([Figure 5](#fig5){ref-type="fig"}E). When individual CFU colonies were harvested and reseeded for limiting dilution assay, CFU colonies from FR^High^ hES-MSCs showed two times the clonogenic activity than those from FR^Low^ cells ([Figure 5](#fig5){ref-type="fig"}F), indicating the enhanced self-renewal activity of FR^High^ hES-MSCs. FR^High^ cells in both types of SCs showed significantly enhanced chemoattraction to stromal derived factor 1 compared with naive or FR^Low^ cells ([Figure 5](#fig5){ref-type="fig"}G). The improved chemotactic activities in FR^High^ cells were also found by PDGF stimuli and were significantly blocked by a PDGF receptor (PDGFR) inhibitor, STI571 ([Figure 5](#fig5){ref-type="fig"}H). Accordingly, FR^High^ hES-MSCs showed significantly higher mRNA levels of pluripotency- or migration-related genes than did naive and FR^Low^ cells, including *OCT4* and *CXCR4* ([Figure 5](#fig5){ref-type="fig"}I).

To prove the functional role of high GSH levels, we depleted cellular GSH in FR^High^ hES-MSCs using BSO and found that GSH depletion severely impaired the enhanced clonogenic and migration capacities as well as upregulation of the related genes observed in FR^High^ hES-MSCs ([Figures 5](#fig5){ref-type="fig"}J--5L, [S6](#mmc1){ref-type="supplementary-material"}C, and S6D). In line with these data, declined cellular functions in FR^Low^ hES-MSCs were reversed to levels similar to those of FR^High^ cells by glutathione ethyl ester (GSH-EE), a cell-permeable glutathione. Moreover, naive cells treated with BSO and GSH-EE resulted in the significant repression and activation of chemoattraction to PDGF, respectively ([Figure S6](#mmc1){ref-type="supplementary-material"}E).

To further investigate the significance of a high GSH content among other types of SC, we fractionated murine ESCs (mESCs) into higher- and lower-GSH level cells based on the FR of FreSHtracer ([Figures 6](#fig6){ref-type="fig"}A and 6B). Compared with FR^Low^ mESCs, FR^High^ cells displayed remarkably enhanced cellular function regarding GSH recovery capacity following H~2~O~2~ treatment ([Figures 6](#fig6){ref-type="fig"}C and 6D) and exhibited dome-like morphological colonies with positive alkaline phosphatase staining, characteristic of undifferentiated ESCs ([Figure 6](#fig6){ref-type="fig"}E). Additionally, FR^High^ mESCs were superior to FR^Low^ cells in terms of clonogenic efficiency as exhibited in the limiting dilution assay representing self-renewal activity ([Figure 6](#fig6){ref-type="fig"}F) and greater expression of pluripotency-related genes ([Figures 6](#fig6){ref-type="fig"}G and 6H). When they were differentiated by forming embryoid bodies (EBs), FR^Low^ mESCs exhibited defects in EB formation ([Figure 6](#fig6){ref-type="fig"}I) and induction of several lineage markers, such as neural (e.g., *Neurog2* and *Olig2*) and mesodermal (e.g., *T* and *Nkx2*.*5*) markers ([Figures 6](#fig6){ref-type="fig"}J and [S6](#mmc1){ref-type="supplementary-material"}F). The defective differentiation capacity in cells from FR^Low^ EB was further validated by *in vitro* neuronal differentiation, evidenced by a lack of βIII-tubulin^+^ neurons ([Figure 6](#fig6){ref-type="fig"}K) and by impaired induction of neuronal markers ([Figure 6](#fig6){ref-type="fig"}L). Taken together, these findings demonstrate that high cellular GSH levels are required for maintaining the core functions in SCs.Figure 6Impaired Pluripotency and Differentiation in Murine Embryonic Stem Cells with Low GSH Levels(A) Sorting of murine ESCs (mESCs) according to the F~510~/F~580~ ratio (FR) into FR^High^ and FR^Low^ populations.(B) Luminescence-based quantification of GSH in cell lysates (n = 4 independent biological replicates).(C and D) Representative pseudo-colored confocal images of the FR (C) and the comparison of their FR changes (n = 4 cells; D) in FR^High^ and FR^Low^ mESCs, following treatment with 100 μM H~2~O~2~. Scale bars, 10 μm.(E) Representative pictures for bright-field (upper panel) and alkaline phosphatase (AP) staining (lower panel). Scale bars, 200 μm.(F--H) Clonogenic capacity in limiting dilution (n = 5 independent biological replicates; F), qPCR (n = 4 independent biological replicates; G), and western blot (H) analyses in FR^High^ and FR^Low^ mESCs and in unsorted control (naive) cells.(I) Representative pictures (left) and quantitation (n = 6 independent biological replicates; right) for size of 5-day embryoid body (EB) formed from FR^High^ and FR^Low^ mESCs. Scale bars, 200 μm.(J) qPCR analyses for lineage-specific genes (*Neurog2*, *Olig2*, *T*, and *Nkx2*.*5*) in EBs at the indicated day (n = 4 independent biological replicates).(K and L) Immunostaining of βIII-tubulin^+^ neuron cells (green; K) qPCR analyses of neural lineage markers (*Neurog1*, *Neurod1*, *Nkx2*.*2*, *Ascl2*, *Gfap*, *S100b*, and *Olig2*; n = 4 independent biological replicates; L) during ESC differentiation. Nuclei were counterstained with DAPI (blue; K). The βIII-tubulin^+^ neuron cells were quantitated by their frequency in total DAPI^+^ cells (n = 5 independent biological replicates; K, right panel). Scale bars, 100 μm.Values represent mean ± SEM; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

GSH^High^ Stem Cells Show Higher Therapeutic Effectiveness in a Mouse Model of Asthma {#sec2.6}
-------------------------------------------------------------------------------------

To confirm these results *in vivo*, we compared the therapeutic effectiveness of FR^High^ and FR^Low^ hES-MSCs in a mouse model of virus-associated asthma. The mice were sensitized and challenged with ovalbumin and poly(I:C) and then injected with the sorted or naive hES-MSCs via the tail vein ([Figure 7](#fig7){ref-type="fig"}A). Histological examination showed that inflammatory responses were markedly attenuated around the bronchial and perivascular areas in the lungs of the FR^High^ cell-injected mice compared with those of the FR^Low^ or naive cell-injected mice ([Figure 7](#fig7){ref-type="fig"}B). The number of inflammatory cells in the bronchoalveolar lavage fluid from FR^High^ cell-injected mice was lower than that from FR^Low^ or naive cell-injected mice ([Figure 7](#fig7){ref-type="fig"}C). Similarly, tumor necrosis factor α (TNF-α) and interleukin-17 (IL-17) levels were lower, whereas IL-10 levels were higher in the bronchoalveolar lavage fluid from FR^High^ cell-injected mice ([Figure 7](#fig7){ref-type="fig"}D). qRT-PCR confirmed the significantly decreased mRNA levels of inflammatory cytokines in the lung tissues of FR^High^ cell-injected mice ([Figure 7](#fig7){ref-type="fig"}E). Moreover, immunohistochemical staining with human β~2~-microglobulin antibody showed a marked increase of engrafted cells in the lungs of FR^High^ hES-MSC-injected mice, which were identified as type-2 alveolar cells by staining with anti-prosurfactant protein C (SFTPC) antibody ([Figures 7](#fig7){ref-type="fig"}F and [S7](#mmc1){ref-type="supplementary-material"}). These results indicated that the injected hES-MSCs differentiated into the alveolar epithelium ([@bib21], [@bib32]), contributing to tissue regeneration. Taken together, these results suggest that GSH levels can be used as a marker to evaluate SC function for enhancing the therapeutic potency.Figure 7Stem Cells with High GSH Levels Exhibit Increased Therapeutic Efficacy(A) Scheme for establishment of the poly(I:C)-induced mouse model of asthma.(B--F) Naive, FR^High^, and FR^Low^ hES-MSCs, or PBS were administered to mice treated with ovalbumin (OVA) and poly(I:C). (B) H&E staining of lung tissues. Sham, sham-operated. (C) Number of total cells, macrophages, neutrophils, lymphocytes, and eosinophils (n = 30 independent biological replicates from n = 10 mice) and (D) ELISA-based detection of TNF-α, IL-10, and IL-17 in the bronchoalveolar lavage fluid (n = 10 independent biological replicates from n = 10 mice). (E) qPCR analysis of *Tnfa*, *Clcl2*, *Il1b*, *Il12a*, and *Il18* expression using RNA isolated from the lung tissues (n = 10 independent biological replicates from n = 10 mice). (F) Immunofluorescent staining of human β-2 microglobulin expression (hB2M, red) and prosurfactant protein C (SFTPC, green) in the lung tissues. Nuclei were stained with DAPI (blue).For all bar graphs, values represent mean ± SEM; ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001; n.s., not significant. Scale bars, 200 μm (B and F). See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

GSH, the most abundant non-protein thiol in cells, functions as a redox buffer, preventing oxidative damage and regulating redox signaling. Therefore, the intracellular GSH level has been used as an important indicator to assess the intensity of oxidative stress ([@bib36]). Since GSH levels are continuously fluctuating, owing to its regeneration and increased *de novo* synthesis under oxidative stress conditions ([@bib23]), the real-time monitoring of GSH levels is required for a detailed analysis of the strength and duration of oxidative damage and consequent redox signaling. In the present study, we demonstrated that FreSHtracer, a chemical probe with the ability to undergo reversible addition reactions with thiols, can be used to monitor and measure GSH levels in living cells. The reaction with GSH induces changes in the fluorescence excitation and emission of the probe, which enables the ratiometric measurement of GSH, thus excluding the possible errors caused by different uptake of the FreSHtracer dye for individual cells and a specific organelle. FreSHtracer readily penetrates through cell membranes, and can report GSH levels with no cytotoxicity under both physiological and various ROS-generating conditions. More importantly, our detail *in vitro* kinetic and *in vivo* cellular studies showed that the FreSHtracer probe can successfully distinguish GSH from protein thiols ([Figures 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}). This simple, rapid, and ratiometric method is well suited for studying GSH dynamics of SCs using various techniques, including microscopic and flow-cytometric analyses.

Our results showed that GSH levels are much higher in the nucleus than in the cytosol, as proposed previously ([@bib9]). In addition, GSH levels decreased in the nucleus and cytosol to a similar extent, and maintained a concentration gradient under oxidative stress conditions, suggesting an unidentified mechanism that transports GSH into the nucleus against such a gradient. The maintenance of high GSH levels in the nucleus also suggests that GSH regulates DNA synthesis, transcription, and repair through modulation of redox signaling ([@bib9]).

Mitochondrial GSH (mGSH) constitutes 10%--15% of the total cellular GSH pool and is imported from the cytosol to play a major role in maintaining mitochondrial redox homeostasis ([@bib24]). Our results with MitoFreSHtracer demonstrated that the mGSH levels differ among the mitochondria in a single cell. Such heterogeneity of mGSH levels might reflect differences in the activity of GSH transporters, rate of ROS production, and/or activity of NADPH production. With defects in these activities, depletion of mGSH results in DNA damage or apoptotic cell death and contributes to the pathogenesis of a number of diseases ([@bib24]). Thus, MitoFreSHtracer could become an indispensable tool for investigating the regulation of mGSH in a variety of contexts.

A low ROS level is critical to preserve the self-renewal process of SCs ([@bib27]) as well as to prevent mutations or damage that could impair their genetic and epigenetic integrity ([@bib2], [@bib12]). Hematopoietic SCs with low ROS levels sorted by dichlorofluorescence staining exhibited long-term repopulating capacity ([@bib17]). Consistently, we demonstrated that GSH levels were well correlated with the self-renewal activity of SCs. These results provide insight into the role of GSH in regulating redox signaling, which plays an important role in determining the SC fate, possibly modulating the activities of transcriptional factors such as NRF2 or FoxOs ([@bib2]). Thus, monitoring of cellular GSH is necessary to evaluate SC function.

There is conflicting evidence on the role of ROS in the regulation of SC activities. ROS generated by Nox1 in neural SCs or by Nox2 in spermatogonial SCs were shown to be required for their self-renewal activity ([@bib22], [@bib28]). In contrast, ROS exhibited inhibitory effects on SC function ([@bib20], [@bib30]). In addition, the defective hematopoietic SC functions observed in *Nrf2*-deficient mice were found to be independent of the ROS level ([@bib26]). These seemingly contradictory results might be attributed to microenvironment- and cell-type-specific mechanisms. Embryonic or quiescent adult SCs minimize ROS production by residing within a specialized niche with a relatively low oxygen concentration (1%--8%) in the body ([@bib27]) and by depending on anaerobic glycolysis through low mitochondrial biogenesis ([@bib15]). Moreover, in the present study, GSH^High^ SCs exhibited greater GSH-regenerating activity than GSH^Low^ SCs ([Figures 5](#fig5){ref-type="fig"}C and [6](#fig6){ref-type="fig"}D). Therefore, the intrinsic activities of GSH synthesis and regeneration, rather than the amount of ROS produced, are responsible for determining the effect of ROS on cellular function.

Flow-cytometric analysis of SC populations revealed substantial heterogeneity of GSH levels among individual cells, and GSH^High^ cell fractionation using FreSHtracer showed the enhanced functionalities evidenced in both *in vitro* and *in vivo* analyses. Importantly, we found that this heterogeneity of GSH levels changed in the SC population with increasing passage numbers ([Figure 4](#fig4){ref-type="fig"}F). These findings indicate that SCs respond differently to oxidative stress even under exposure to an atmospheric oxygen concentration (21%). Further work is needed to investigate the mechanism by which GSH levels are differentially regulated in SCs in response to ROS. FreSHtracer is a useful tool for the real-time monitoring of intracellular GSH levels in living SCs and for fractionating cells according to their GSH levels. Comparison of the signaling pathways between GSH^High^ and GSH^Low^ cells could be helpful in identifying the key players involved in the GSH regulation of SCs.

In summary, we demonstrated that FreSHtracer could be used for studying various aspects of GSH homeostasis, including synthesis, transport, and regeneration. Spatiotemporal information regarding intracellular GSH levels in living cells might facilitate detailed investigations into the molecular mechanisms contributing to altered cellular functions in response to internal and external stresses. During the preparation of this paper, recent studies also reported very similar coumarin derivatives for the monitoring of GSH levels inside HeLa cells ([@bib4], [@bib18]).

Experimental Procedures {#sec4}
=======================

Detailed methods are provided in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Cell Lines and Culture {#sec4.2}
----------------------

HeLa and RAW264.7 cells were purchased from the Korean Cell Line Bank (Seoul, Korea) and the American Type Culture Collection (ATCC; Manassas, VA), respectively. The cells were grown in phenol red-free DMEM (Welgene, LM 001-10; Gyeongsan, Korea) supplemented with 10% heat-inactivated fetal bovine serum (HyClone; GE Healthcare, Melbourne, VIC, Australia), 100 U/mL penicillin, 100 μg/mL streptomycin sulfate, and 2 mM glutamine. hES-MSCs were kindly provided by Hyung-Min Chung (Konkuk University, Korea). Cellular GSH of hES-MSCs was depleted by treating cells with 80 μM BSO (Sigma-Aldrich, St. Louis, MO) for 24 hr and was restored with 1 mM GSH-EE (Sigma-Aldrich) for 2 hr, followed by their functional assays. hBM-MSCs (Lonza, Walkersville, MD) were cultured according to the manufacturer\'s instructions. Culture, EB formation, and *in vitro* neuronal differentiation of murine E14TG2a ESCs (ATCC) were performed as previously described ([@bib12]).

Confocal Imaging of the Fluorescence Ratio within Living Cells {#sec4.3}
--------------------------------------------------------------

HeLa cells (1.8 × 10^5^ cells/dish), RAW264.7 cells (2 × 10^5^ cells/dish), hBM-MSCs (8 × 10^4^ cells/dish), hES-MSCs (1.5 × 10^5^ cells/dish), and murine E14TG2a ESCs (5 × 10^5^ cells/dish) were seeded onto 35-mm coverglass-bottom dishes (SPL Life Sciences, Pocheon, Korea) and cultured at 37°C in a 5% CO~2~ incubator for 16--20 hr. The cells were then equilibrated with 5 μM FreSHtracer in 2 mL of culture medium, followed by microscopic analysis. For mitochondrial GSH imaging, HeLa cells were incubated with 10 μM MitoFreSHtracer for 1.5 hr, washed twice with PBS, and analyzed in 2 mL of fresh culture medium using a confocal microscope. Time-lapse imaging of the cells was performed using a Nikon A1 laser-scanning confocal microscope. The cells were maintained at 37°C in a 5% CO~2~ atmosphere by a stage-top incubator. The chamber was mounted on a Nikon ECLIPSE Ti inverted microscope, equipped with a CFI Plan apochromat 60×, 1.40-numerical aperture (NA) objective (oil immersion) or a CFI Plan apochromat 20×, 0.8-NA objective. FreSHtracer was excited by lasers at 405 nm and 488 nm, and the emissions were detected through 500- to 550-nm and 570- to 620-nm band-pass filters. Cells in the focused area were gently treated with 20 μL of 100× concentrated solutions of H~2~O~2~, diamide, or DTT. Data were analyzed and pseudo-color ratio images were generated using NIS-Elements AR software. FreSHtracer was prepared according to our previously reported method ([@bib5]). This probe is now commercially available (Cell2in, Seoul, Korea).

Animal Study Approval {#sec4.1}
---------------------

All animal experiments were approved and performed in accordance with guidelines set by the Institutional Animal Care and Use Committee of the University of the Ulsan College of Medicine (2015-12-061).

Statistical Analysis {#sec4.4}
--------------------

We used a two-sided t test for single pairwise comparisons. We also used one-way ANOVA with a Tukey post hoc test for multiple comparisons. Values are expressed as the mean and SEM. All statistical analyses were performed using GraphPad Prism 5 software.
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